Chronic use of sodium ferric gluconate complex in hemodialysis patients: Safety of higher-dose (≥250 mg) administration
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 41 (3), 651-657
- https://doi.org/10.1053/ajkd.2003.50141
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiencyKidney International, 2001
- Sodium ferric gluconate complex in the treatment ofiron deficiency for patients on dialysisAmerican Journal of Kidney Diseases, 2001
- Intravenous iron dextran treatment in predialysis patients with chronic renal failureAmerican Journal of Kidney Diseases, 2000
- Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American clinical trialAmerican Journal of Kidney Diseases, 1999
- Intravenous iron for the treatment of predialysis anemiaKidney International, 1999
- Iron management in end-stage renal diseaseAmerican Journal of Kidney Diseases, 1997
- A randomized controlled study of iron supplementation in patients treated with erythropoietinKidney International, 1996
- Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysisAmerican Journal of Kidney Diseases, 1996
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Iron Balance in Hemodialysis PatientsAnnals of Internal Medicine, 1977